BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

BioDelivery Sciences International 

2501 Aerial Center Parkway, Suite 205

Morrisville  North Carolina  27560  U.S.A.
Phone: 919-651-5160 Fax: 919-651-5161


SEARCH JOBS

View Clinical Trials from BioPharm Insight



Industry
Biotechnology

Segment
Drug Delivery





 Company News
BioDelivery Sciences International (BDSI) Launches InReach Support Program For Those Affected By Opioid Dependence 12/10/2014 8:34:06 AM
BioDelivery Sciences International (BDSI) Announces Completion Of Randomization In Phase 3 Trial Of Clonidine Topical Gel For The Treatment Of Painful Diabetic Neuropathy 12/8/2014 8:07:07 AM
BioDelivery Sciences International (BDSI) To Present At The 26th Annual Piper Jaffray Healthcare Conference 11/25/2014 10:43:53 AM
BioDelivery Sciences International (BDSI) To Present At The Stifel 2014 Healthcare Conference And The Jefferies and Co. 2014 Global Healthcare Conference 11/13/2014 8:50:22 AM
BioDelivery Sciences International (BDSI) To Present At The Credit Suisse 2014 Healthcare Conference 11/7/2014 10:00:40 AM
BioDelivery Sciences International (BDSI) Provides Business Review And Update In Conjunction With Filing Of Third Quarter 2014 Financials 11/6/2014 7:50:42 AM
BioDelivery Sciences International (BDSI) Announces The Availability Of BUNAVAILâ„¢ In The U.S. 11/3/2014 8:17:35 AM
BioDelivery Sciences International (BDSI)To Develop A Long-Acting Injectable Depot Formulation Of Buprenorphine With Evonik Industries For Use In Opioid Dependence And Pain 10/28/2014 8:30:53 AM
BioDelivery Sciences International (BDSI) Announces The Hiring Of J. Chris Prue As Vice President Of Regulatory Affairs And Quality Assurance 10/10/2014 9:28:25 AM
BioDelivery Sciences International (BDSI) To Provide BUNAVAIL Launch Update 10/7/2014 8:39:22 AM
12345678910...